PerkinElmer: Our Parent Company
Both ViaCord and PerkinElmer, our parent company, share the same goal – to help save lives. As the world’s leading provider of neonatal screening systems, PerkinElmer has helped identify more than 100,000 newborns at risk of inherited metabolic disorders. ViaCord offers expecting families the unique combination of cord blood expertise and the piece of mind that comes with PerkinElmer’s strength and stability.
Because ViaCord is part of PerkinElmer, a publicly-traded company, our financial and corporate information is available to the public and we comply with all SEC guidelines and regulations. This means you'll have access to important information about us, including our financial stability.
PerkinElmer believes a healthier future starts with the work we do today.
Watch a brief overview of PerkinElmer's mission, business and values.
About PerkinElmer
PerkinElmer is a leader in human and environmental health. Our expertise combines science, innovation and a culture of operational excellence to offer customers technology services and support that improve the quality of people's lives worldwide.
Whether it's testing newborns for life-threatening disorders, supporting scientists in finding better cures, or helping doctors treat disease, the focus on human health extends beyond the lab and into hospitals and homes. With innovative screenings and treatments, as well as ongoing development of advanced life science tools, PerkinElmer helps generate earlier medical insights, more accurate results, and more effective therapies.
Our work in environmental health improves the quality and sustainability of our environment, and the security of people in the places where we live, work and play. This includes providing the analytical instrumentation, and services that ensure clean air and water; safe food and consumer products; and efficient, renewable energy - the essential components of a healthier, safer today and tomorrow.
PerkinElmer serves customers in more than 150 countries and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.